Comparison between Amagi Media Labs IPO and Sahajanand Medical Technologies IPO.
Amagi Media Labs IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Sahajanand Medical Technologies IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Amagi Media Labs IPO is up to ₹1,788.62 Cr whereas the issue size of the Sahajanand Medical Technologies IPO is up to ₹0.00 Cr. The final issue price of Amagi Media Labs IPO is ₹361.00 per share and of Sahajanand Medical Technologies IPO is .
| Amagi Media Labs IPO | Sahajanand Medical Technologies IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹1 per share |
| Issue Price (Lower) | ₹343.00 per share | |
| Issue Price (Upper) | ₹361.00 per share | |
| Issue Price (Final) | ₹361.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 41 shares | |
| Fresh Issue Size | 2,26,03,878 shares | 0 shares |
| Fresh Issue Size (Amount) | up to ₹816.00 Cr | up to ₹0.00 Cr |
| OFS Issue Size | 2,69,42,343 shares | 2,76,44,231 shares |
| OFS Issue Size (Amount) | up to ₹972.62 Cr | up to ₹0.00 Cr |
| Issue Size Total | 4,95,46,221 shares | 2,76,44,231 shares |
| Issue Size Total (Amount) | up to ₹1,788.62 Cr | up to ₹0.00 Cr |
Amagi Media Labs IPO opens on Jan 13, 2026, while Sahajanand Medical Technologies IPO opens on . The closing date of Amagi Media Labs IPO and Sahajanand Medical Technologies IPO is Jan 16, 2026, and , respectively.
| Amagi Media Labs IPO | Sahajanand Medical Technologies IPO | |
|---|---|---|
| Anchor Bid Date | Jan 12, 2026 | |
| Issue Open | Jan 13, 2026 | |
| Issue Close | Jan 16, 2026 | |
| Basis Of Allotment (Tentative) | Jan 19, 2026 | |
| Initiation of Refunds (Tentative) | Jan 20, 2026 | |
| Credit of Share (Tentative) | Jan 20, 2026 | |
| Listing date (Tentative) | Jan 21, 2026 | |
| Anchor Lockin End date 1 | Feb 17, 2026 | |
| Anchor Lockin End date 2 | Apr 18, 2026 |
Amagi Media Labs IPO P/E ratio is -101.78, as compared to Sahajanand Medical Technologies IPO P/E ratio of .
| Amagi Media Labs IPO | Sahajanand Medical Technologies IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)Sahajanand Medical Technologies Ltd.'s revenue increased by 14% and profit after tax (PAT) rose by 442% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 15.76 | 40.92 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 14.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | -101.78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹7809.84 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 3.68% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 10.37% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹-3.55 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | -13.49% | 3.73% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Amagi Media Labs IPO Retail Individual Investors (RII) are offered 49,54,622 shares while in Sahajanand Medical Technologies IPO retail investors are offered 49,54,622 shares. Qualified Institutional Buyers (QIB) are offered 1,48,63,867 shares in Amagi Media Labs IPO and 0 shares in Sahajanand Medical Technologies IPO.
| Amagi Media Labs IPO | Sahajanand Medical Technologies IPO | |
|---|---|---|
| Anchor Investor Reservation | 2,22,95,799 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 1,48,63,867 shares | 0 shares |
| NII | 74,31,933 shares | 0 shares |
| RII | 49,54,622 shares | 0 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 4,95,46,221 shares | 0 shares |
Amagi Media Labs IPO subscribed 30.24x in total, whereas Sahajanand Medical Technologies IPO subscribed .
| Amagi Media Labs IPO | Sahajanand Medical Technologies IPO | |
|---|---|---|
| QIB (times) | 33.13x | |
| NII (times) | 38.26x | |
| Big NII (times) | 44.24x | |
| Small NII (times) | 26.29x | |
| RII (times) | 9.54x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 30.24x |
